EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The limitless endophytes: their role as antifungal agents against top priority pathogens

Ashaimaa Y Moussa

Microbial Cell Factories · 2024

DOI: 10.1186/s12934-024-02411-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Microbial Cell Factories, 2024. Verfasst von Ashaimaa Y Moussa. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, African Union Organization Street, Abbassia, Cairo, 11566, Egypt. ashaimaa_ye…. Hauptthemen laut MEDLINE: Antifungal Agents, Endophytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Science, Technology & Innovation Funding Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multi resistant fungi are on the rise, and our arsenal compounds are limited to few choices in the market such as polyenes, pyrimidine analogs, azoles, allylamines, and echinocandins. Although each of these drugs featured a unique mechanism, antifungal resistant strains did emerge and continued to arise against them worldwide. Moreover, the genetic variation between fungi and their host humans is small, which leads to significant challenges in new antifungal drug discovery. Endophytes are still an underexplored source of bioactive secondary metabolites. Many studies were conducted to isolate and screen endophytic pure compounds with efficacy against resistant yeasts and fungi; especially, Candida albicans, C. auris, Cryptococcus neoformans and Aspergillus fumigatus, which encouraged writing this review to critically analyze the chemical nature, potency, and fungal source of the isolated endophytic compounds as well as their novelty features and SAR when possible. Herein, we report a comprehensive list of around 320 assayed antifungal compounds against Candida albicans, C. auris, Cryptococcus neoformans and Aspergillus fumigatus in the period 1980–2024, the majority of which were isolated from fungi of orders Eurotiales and Hypocreales associated with terrestrial plants, probably due to the ease of laboratory cultivation of these strains. 46% of the reviewed compounds were active against C. albicans, 23% against C. neoformans, 29% against A. fumigatus and only 2% against C. auris . Coculturing was proved to be an effective technique to induce cryptic metabolites absent in other axenic cultures or host extract cultures, with Irperide as the most promising compounds MIC value 1 μg/mL. C. auris was susceptible to only persephacin and rubiginosin C. The latter showed potent inhibition against this recalcitrant strain in a non-fungicide way, which unveils the potential of fungal biofilm inhibition. Further development of culturing techniques and activation of silent metabolic pathways would be favorable to inspire the search for novel bioactive antifungals. Graphic abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsEndophytesHumansMicrobial Sensitivity TestsCryptococcus neoformansFungiAspergillus fumigatusCandida albicans

Stichwörter der Autor:innen

AntifungalCocultureEndophytesFungal biofilmMulti-resistant fungi

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, African Union Organization Street, Abbassia, Cairo, 11566, Egypt. ashaimaa_yehia@pharma.asu.edu.eg.

Förderung

  • The Science, Technology & Innovation Funding Authority

Zitieren

APA

Moussa, A. Y. (2024). The limitless endophytes: their role as antifungal agents against top priority pathogens. Microbial Cell Factories. https://doi.org/10.1186/s12934-024-02411-3

Vancouver

Moussa AY. The limitless endophytes: their role as antifungal agents against top priority pathogens. Microbial Cell Factories. 2024. doi:10.1186/s12934-024-02411-3

BibTeX
@article{Moussa2024,
  author = {Moussa, Ashaimaa Y},
  title = {The limitless endophytes: their role as antifungal agents against top priority pathogens},
  journal = {Microbial Cell Factories},
  year = {2024},
  doi = {10.1186/s12934-024-02411-3}
}
Kostenlos starten →